Delirium, Dementia, Amnestic, Cognitive Disorders  >>  RO5313534  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RO5313534 / Roche
NCT00454870: Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

Completed
2
80
US
MEM 3454
Memory Pharmaceuticals
Alzheimer's Disease
10/07
10/07
NCT00884507 / 2008-004012-13: A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Completed
2
389
US, Canada, Europe, RoW
Placebo, RO5313534
Hoffmann-La Roche
Alzheimer's Disease
11/10
11/10

Download Options